Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful
Korean Journal of Radiology
;
: 54-70, 2017.
Article
Dans Anglais
| WPRIM
| ID: wpr-208835
ABSTRACT
Diffuse large B cell lymphoma (DLBCL) is the most common histological subtype of Non-Hodgkin's lymphoma. As treatments continues to evolve, so do imaging strategies, and positron emission tomography (PET) has emerged as the most important imaging tool to guide oncologists in the diagnosis, staging, response assessment, relapse/recurrence detection,and therapeutic decision making of DLBCL. Other imaging modalities including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and conventional radiography are also used in the evaluation of lymphoma. MRI is useful for nervous system and musculoskeletal system involvement and is emerging as a radiation free alternative to PET/CT. This article provides a comprehensive review of both the functional and morphological imaging modalities, available in the management of DLBCL.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Lymphome malin non hodgkinien
/
Imagerie par résonance magnétique
/
Lymphocytes B
/
Radiographie
/
Lymphome B
/
Échographie
/
Prise de décision
/
Tomographie par émission de positons
/
Diagnostic
/
Tomographie par émission de positons couplée à la tomodensitométrie
Type d'étude:
Etude diagnostique
langue:
Anglais
Texte intégral:
Korean Journal of Radiology
Année:
2017
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS